vancomycin hydrochloride
vancomycin hydrochloride is listed in the FDA National Drug Code directory with 53 NDC codes, marketed under brand names including Vancomycin Hydrochloride, VANCOMYCIN HYDROCHLORIDE, FIRVANQ. Available dosage forms: injection, powder, lyophilized, for solution, injection, powder, for solution, kit, capsule.
Drug details
- Generic Name
- vancomycin hydrochloride
- Brand Names
- Vancomycin Hydrochloride, VANCOMYCIN HYDROCHLORIDE, FIRVANQ, vancomycin hydrochloride, Vancomycin Hydrochloride for Oral Solution, Vancomycin, Vancocin
- Application Number
- ANDA205694
- Sponsor
- Xellia Pharmaceuticals USA LLC
- NDC Codes
- 53
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, INJECTION, POWDER, FOR SOLUTION, KIT, CAPSULE
- Routes
- INTRAVENOUS, ORAL
- Active Ingredients
- VANCOMYCIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Vancomycin Hydrochloride Capsules are indicated for the treatment of C. difficile -associated diarrhea. Vancomycin Hydrochloride Capsules are also used for the treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients less than 18 years of age. Vancomycin hydrochloride capsules are glycopeptide antibacterial indicated in adult and pediatric patients (less than 18 years of age) for the treatment of: ( 1 ) C. difficile -associated diarrhea Enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) Limitations of Use : ( 1 ) ( 5.1 ) Parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin hydrochloride capsules must be given orally for these infections. Orally administered vancomycin hydrochloride capsules are not effective for other types of infections. To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1 ) Limitations of Use Parenteral administration of vancomycin is not effective for the above infections; therefore, Vancomycin Hydrochloride Capsules must be given orally for these infections. Orally administered Vancomycin Hydrochloride Capsules is not effective for other types of infections. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Vancomycin Hydrochloride Capsules and other antibacterial drugs, Vancomycin Hydrochloride Capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.